Enterococcus faecalis is firmly Gram-positive, meaning it retains the crystal violet stain used in the classic Gram staining procedure and appears dark purple under a microscope.1PubMed Central. Structure, function, and biology of the Enterococcus faecalis cytolysin This is not a borderline or debatable classification. Every recognized species in the genus Enterococcus shares that Gram-positive identity, and E. faecalis is arguably the most studied member of the group. But what makes this bacterium interesting goes well beyond staining behavior: it lives quietly in your gut yet ranks among the leading causes of hospital-acquired infections, and its cell wall architecture is central to both of those roles.
What Gram-Positive Actually Means for This Organism
The Gram stain, developed in the 1880s, splits most bacteria into two broad camps based on the structure of their outer envelope. Gram-positive bacteria have a thick layer of peptidoglycan, a mesh-like polymer that sits outside the cell membrane and traps the purple dye during staining. Gram-negative bacteria have a much thinner peptidoglycan layer sandwiched between two membranes, and they lose the purple dye during a wash step, picking up a pink counterstain instead.
In E. faecalis, peptidoglycan is a major structural component of the cell wall.2PubMed Central. Peptidoglycan Compositional Analysis of Enterococcus faecalis Biofilm by Stable Isotope Labeling by Amino Acids in a Bacterial Culture Detailed structural work using solid-state nuclear magnetic resonance has shown that E. faecalis peptidoglycan has a hybrid architecture, with a mix of parallel and perpendicular stems cross-linked at close to the ideal fifty percent level.3PubMed Central. Characterization of the tertiary structure of the peptidoglycan of Enterococcus faecalis This thick, well-organized mesh matters clinically. It determines which antibiotics can target the organism, since many drugs work by disrupting peptidoglycan assembly. It also provides physical toughness, helping the bacterium survive conditions that would kill more fragile species.
A Gut Commensal That Can Turn Dangerous
Under normal circumstances, E. faecalis is a harmless resident of the gastrointestinal tract. It colonizes the guts of a remarkably wide range of animals, from insects and birds to reptiles and mammals, humans included.4Trends in Microbiology. Enterococcus faecalis In the gut, it is just one member of a vast microbial community, kept in check by competing bacteria and by the physical barrier of the intestinal lining.
The trouble starts when those checks fail. Antibiotic use can wipe out competing gut flora, giving E. faecalis room to overgrow. Severe inflammation or surgical damage to the intestinal wall can allow the bacterium to cross into the bloodstream. Once outside the gut, E. faecalis behaves very differently. It is associated with bloodstream infections, endocarditis (infection of the heart valves), peritonitis, surgical site infections, and catheter-associated urinary tract infections.4Trends in Microbiology. Enterococcus faecalis Together with its relative Enterococcus faecium, it accounts for the majority of enterococcal infections in healthcare settings.5PubMed Central. The Enterococcus: a Model of Adaptability to Its Environment
Researchers have probed this commensal-to-pathogen switch directly. In experiments using the tobacco hornworm caterpillar as a model host, E. faecalis persisted peacefully in the harsh midgut environment without causing illness. But when the same bacteria were injected directly into the body cavity, bypassing the gut barrier, the insects died rapidly.6PubMed Central. From commensal to pathogen: translocation of Enterococcus faecalis from the midgut to the hemocoel of Manduca sexta The lesson is that location matters enormously. E. faecalis is not inherently aggressive in the way some pathogens are; it becomes dangerous when it escapes the compartment where the body expects it to be.
Why E. faecalis Is So Hard to Kill
One of the things that sets E. faecalis apart from other gut-dwelling lactic acid bacteria is its ability to shrug off environmental stress. It tolerates heat, acid, oxidative damage, and high salt concentrations, and researchers suspect this intrinsic toughness contributes to its potential as a pathogen.7PLOS ONE. Transcriptomic and Functional Analysis of NaCl-Induced Stress in Enterococcus faecalis In practical terms, this means the bacterium can survive on hospital surfaces, in food processing environments, and in conditions that would eliminate less hardy organisms.
That environmental resilience is compounded by resistance to antibiotics. E. faecalis carries intrinsic resistance to several drug classes, meaning the resistance is baked into its biology rather than acquired from other bacteria. The mechanisms can be intrinsic to the species or picked up through mutations in existing genes or through horizontal transfer of resistance genes from other microbes.8PubMed Central. Intrinsic and acquired resistance mechanisms in enterococcus Vancomycin resistance is the most alarming acquired trait. Several gene clusters can confer it, including vanA and vanD. The vanA gene has been found on transferable genetic elements, making it capable of spreading between strains. In one study of vancomycin-resistant E. faecalis isolates, the vanA gene was carried on an intact transposon, a mobile piece of DNA that can hop between chromosomes and plasmids.9PubMed. Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital Other strains harbor the vanD gene cluster on their chromosome, which confers moderate vancomycin resistance but does not transfer by conjugation.10PubMed Central. VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis
Vancomycin-resistant enterococci, or VRE, pose a genuine clinical challenge because vancomycin is often considered a last-resort antibiotic for Gram-positive infections. When it stops working, treatment options narrow considerably.
Biofilm Formation and Medical Devices
If antibiotic resistance makes E. faecalis hard to treat with drugs, biofilm formation makes it hard to reach in the first place. Biofilms are structured communities of bacteria encased in a self-produced matrix of sugars, proteins, and DNA. Once a biofilm forms on a surface, the bacteria inside are shielded from antibiotics and from the immune system.
E. faecalis is a prolific biofilm producer, and the process involves a tangle of genetic factors. Gelatinase, cytolysin, surface proteins, pili, and released extracellular DNA all play roles, coordinated in part by a cell-to-cell signaling system that uses small peptide molecules.11PubMed Central. An Overview of the Factors Involved in Biofilm Production by the Enterococcus Genus One surface protein that has received particular attention is Esp (enterococcal surface protein). In clinical isolates, the presence of the gene encoding Esp is strongly linked to biofilm-forming ability. In one study, over ninety percent of Esp-positive E. faecalis strains could form biofilms, while none of the Esp-negative strains could.12PubMed. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation
This is directly relevant to infections involving catheters, prosthetic heart valves, and other implanted medical devices. Biofilms on these surfaces are notoriously difficult to clear, which is why device-related enterococcal infections often require removing the device entirely rather than relying on antibiotics alone.
How E. faecalis Dodges the Immune System
Beyond building biofilms, E. faecalis has evolved specific strategies to evade host immune defenses. The complement system, a network of blood proteins that tags bacteria for destruction by immune cells, is one of its primary targets. Some strains produce a polysaccharide capsule that physically masks the complement molecules deposited on the bacterial surface, making the bacteria harder for immune cells to recognize and engulf. Capsule-producing strains are more resistant to complement-mediated killing than unencapsulated strains, not because less complement lands on them, but because the capsule hides the deposited complement from detection.13PubMed Central. Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion
Gelatinase, one of the enzymes also involved in biofilm formation, pulls double duty here. It can directly cleave complement protein C3, the central molecule in the complement cascade, into a fragment that quickly becomes inactive. It also degrades complement molecules already deposited on surfaces, reducing how effectively immune cells can phagocytose (swallow and destroy) the bacteria.14The Journal of Immunology. Immune Evasion of Enterococcus faecalis by an Extracellular Gelatinase That Cleaves C3 and iC3b The fact that a single enzyme contributes to both biofilm architecture and immune evasion hints at why gelatinase-producing strains tend to cause more severe infections.
An Unusual Trick for Sharing Genes
E. faecalis has a remarkable system for swapping genetic material between cells, and it helps explain why resistance traits spread so efficiently within the species. Plasmid-free cells secrete small peptides called sex pheromones. When a nearby cell carries a conjugative plasmid (a circular piece of DNA capable of transferring itself), these pheromones trigger a mating response: the donor cell produces a fuzzy surface material that helps it clump together with the recipient, facilitating DNA transfer. Once a cell receives a specific plasmid, it stops producing the pheromone for that plasmid class while continuing to produce pheromones that attract donors carrying other types of plasmids.15PubMed. Sex pheromones and plasmid transfer in Enterococcus faecalis
This is not just a curiosity. Conjugative plasmids are a primary vehicle for the spread of vancomycin resistance genes. The pheromone system makes conjugation in E. faecalis far more efficient than the random encounters most bacteria rely on, meaning resistance can move through a population quickly, especially in environments like hospitals where selective pressure from antibiotics is intense.
Identifying E. faecalis in the Lab
When a clinical lab receives a sample suspected to contain enterococci, the Gram stain is typically the first step. Seeing Gram-positive cocci (round cells) arranged in pairs or short chains points toward enterococci, streptococci, or a few other genera. From there, a relatively simple biochemical key can distinguish among Enterococcus species. One widely used scheme requires only six biochemical tests at most to identify any recognized species in the genus.16PubMed Central. Identification of Enterococcus spp. with a biochemical key Growth in high salt concentrations and at elevated temperatures, along with the ability to hydrolyze certain compounds, helps distinguish enterococci from similar-looking organisms. Modern clinical labs increasingly supplement these classical tests with automated identification systems or molecular methods, but the Gram stain and basic biochemistry remain the foundation.
E. faecalis in Food and Probiotics
Not every encounter with E. faecalis is a threat. The bacterium has a long history in food production, particularly in Mediterranean cheeses. Enterococci colonize the gut naturally and have been used as starter cultures in the manufacture of cheeses with high salt content and low pH. They contribute to the characteristic flavor profiles of traditional cheeses, sausages, and fermented olives and vegetables. Some strains produce bacteriocins, antimicrobial peptides that can inhibit the growth of food-borne pathogens and spoilage organisms, making them candidates for natural food preservation.17Frontiers in Microbiology. Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis
In cheesemaking, the choice of strain matters. Experiments with Cebreiro cheese, a traditional acid-curd cheese from northwestern Spain, showed that adding specific E. faecalis cultures to the starter produced cheeses with organoleptic qualities closely matching the traditional product, but only when strains with moderate enzyme activity were selected. Highly proteolytic strains yielded off flavors.18PubMed. Effects of the addition of Enterococcus faecalis in Cebreiro cheese manufacture The dual identity of this species, beneficial in cheese and dangerous in the bloodstream, makes regulatory attitudes toward enterococci in food complicated. In Europe, some strains are used intentionally in dairy production, while health authorities remain cautious about endorsing enterococci as probiotics given their capacity to acquire and share resistance genes.
Enterococci as Water Quality Indicators
Outside the clinical world, enterococci serve an entirely different public health function. Because they are shed in human and animal feces, are easy to grow in the lab, and their presence correlates with health risks from polluted recreational water, they are used worldwide as fecal indicator bacteria in water quality testing.19PubMed Central. Enterococci in the environment When you see a beach advisory warning about high bacteria counts, enterococci are often the organisms being measured. Their environmental hardiness, the same trait that makes them problematic in hospitals, makes them useful as indicators because they persist in water long enough to be reliably detected. However, that same persistence complicates interpretation: enterococci can sometimes multiply in warm, nutrient-rich sediments or soils, potentially inflating counts in ways that do not necessarily reflect fresh fecal contamination.
Phage Therapy as an Emerging Alternative
With antibiotic resistance narrowing treatment options, researchers have turned to bacteriophages, viruses that specifically infect and kill bacteria, as a potential weapon against drug-resistant E. faecalis. Although phage cocktails targeting E. faecalis are not yet commercially available in the European Union or the United States, the accumulated laboratory and animal evidence is encouraging.20PubMed Central. Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases
In mouse experiments, a single injection of one lytic phage was enough to protect all animals against bloodstream infection caused by a vancomycin-resistant E. faecalis strain.21Frontiers in Microbiology. The Bacteriophage EF-P29 Efficiently Protects against Lethal Vancomycin-Resistant Enterococcus faecalis and Alleviates Gut Microbiota Imbalance in a Murine Bacteremia Model A separate study using a two-phage cocktail in a mouse model of severe septic peritonitis found that a single injection completely reversed what had been a hundred percent mortality trend from vancomycin-resistant E. faecalis, with no harmful effects on the broader gut microbiome.22PubMed. Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model These are animal studies, and the leap to routine human therapy is large, involving regulatory hurdles, manufacturing challenges, and the risk that bacteria will evolve resistance to phages just as they do to antibiotics. Still, phage therapy represents one of the more promising avenues for dealing with infections that antibiotics can no longer reliably clear.
Combination strategies, using phages alongside conventional antibiotics, are also under investigation. The idea is that phages can break open biofilms or reduce bacterial numbers enough for antibiotics to finish the job, even when neither approach would succeed alone. This pairing may also slow the emergence of resistance to either treatment, since bacteria simultaneously evading a virus and a drug face a much steeper evolutionary challenge.